Free shipping on all orders over $ 500

BI-6901 

Cat. No. M29124

All AbMole products are for research use only, cannot be used for human consumption.

BI-6901  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

BI 6901 is a potent, selective CCR10 antagonist (pIC50=9.0). BI 6901 shows high selectivity over other GPCRs, including a number of other chemokine receptors. BI 6901 is efficacious in the murine DNFB model of contact hypersensitivity and can be used for inflammation research.

Chemical Information
Molecular Weight 453.56
Formula C23H27N5O3S
CAS Number 2040401-92-9
Form Solid
Solubility (25°C) DMSO 160 mg/mL (ultrasonic)
Storage 4°C, dry, sealed
Related CCR Products
C-021 dihydrochloride

C-021 dihydrochloride is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 dihydrochloride potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

C-021

C-021 is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

AZD-5672 

AZD-5672 is an orally active, potent, and selective CCR5 antagonist (IC50=0.32 nM).

MLN3126 

MLN3126 is an orally active and potent CCR9 antagonist.

AZD2423 

AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator.

  Catalog
Abmole Inhibitor Catalog




Keywords: BI-6901  supplier, CCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.